Pharmaceutical R&D spending shows modest recovery but far below 1997 plateau
Industry calls for regulatory changes
R&D spending by pharmaceutical companies in Canada inched up in 2005 but not enough to fulfill the 10% R&D-to-sales ratio committed by the industry back in 1987 when government enacted changes to the Patent Act.
Other stories mentioning these organizations, people and topics
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.